Centro Privado de RMI Río Cuarto

Centro Privado de RMI Río Cuarto
CGI, Pedernera 459, X5800CGI Río Cuarto, Córdoba, Argentina
Select an option

Our team

Medical staff
Alejo Lingua

Open studies

Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) - HERTHENA-Breast04 - Merck Sharp & Dohme LLCSee more
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) - IZABRIGHT-Breast01 - Bristol-Myers SquibbSee more
Lung cancer
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - MK 2870-007 - Merck Sharp & Dohme LLCSee more
Kidney cancer
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) - LITESPARK-034 - Merck Sharp & Dohme LLCSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy